An artificial receptor fabricated by target recognition determinant imprinting for selective capture of α-amanitin

Mechanism and treatment of α-amanitin poisoning

Amanita poisoning has a high mortality rate. The α-amanitin toxin in Amanita is the main lethal toxin. There is no specific detoxification drug for α-amanitin, and the clinical treatment mainly focuses on symptomatic and supportive therapy. The pathogenesis of α-amanitin mainly includes: α-amanitin can inhibit the activity of RNA polymeraseII in the nucleus, including the inhibition of the largest subunit of RNA polymeraseII, RNApb1, bridge helix, and trigger loop. In addition, α-amanitin acts in vivo through the enterohepatic circulation and transport system. α-Amanitin can cause the cell death. The existing mechanisms of cell damage mainly focus on apoptosis, oxidative stress, and autophagy. In addition to the pathogenic mechanism, α-amanitin also has a role in cancer treatment, which is the focus of current research. The mechanism of action of α-amanitin on the body is still being explored.

An ion-imprinted imidazole-functionalized ordered mesoporous silica for selective removal of chromium(VI) from electroplating effluents

In this work, ion imprinted technology incorporated with mesoporous silica materials (MCM-41) to obtain the novel specific adsorbent, ion imprinted mesoporous silica. Cr(VI) imprinted mesoporous silica (Cr(VI)IMS) was synthesized and used for adsorption studies and waste water application. A synthesized imidazolyl silane agent act as the functional monomer in the imprinted process to build up highly ordered functionalized imprinted materials. The chemical composition, porosity, and highly ordered morphology were characterized by Fourier transform infrared spectroscopy (FTIR), solid state nuclear magnetic resonance (NMR), Brunauer-Emmett-Teller (BET) method, X-ray diffraction (XRD), transmission electron microscopy (TEM), and scanning electron microscopy (SEM), respectively. The Brunauer-Emmett-Teller (BET) surface area was 1054.51 m² g^-1 in this study. The Cr(VI)IMS showed great adsorption capacity to hexavalent chromium ions in acidic solution up to 45.6 mg g^-1. Cr(VI)IMS reached the adsorption equilibrium in a short time (10 min) at acid and weak acid conditions, while most of adsorbents need more than 30 min to achieve adsorption equilibrium. Cr(VI)IMS displayed much higher adsorption capacity to Cr(VI) ions than other negative ions. The relative selectivity coefficient was 2.56, higher than those of other anions (below 1.5). After eight adsorption-regeneration cycles, the adsorption efficiency of Cr(VI)IMS still reached 92.5%. The Cr(VI)IMS was found to exhibit equivalent property after multiple cycles of experiments, indicating good repeatability and reproducibility.

Highly sensitive determination of amanita toxins in biological samples using β-cyclodextrin collaborated molecularly imprinted polymers coupled with ultra-high performance liquid chromatography tandem mass spectrometry

In this work, a β-cyclodextrin functional vinyl monomer was synthesized and the common moiety of five amanita toxins was used as the template for preparing molecularly imprinted polymers (MIPs). Chemical calculation was used to evaluate and describe the binding interactions between the template and the functional monomer. The preparation conditions were optimized and the resultant MIPs were characterized and employed as solid-phase extraction (SPE) sorbents. The SPE conditions including the amount of sorbent, extraction solution, and eluting solution were also optimized for the enrichment of the five toxins. Using an ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS), detection limits ranging from 0.34-0.42 µg/L, 0.16-0.33 µg/L, and 0.035-0.056 µg/kg were achieved for the five toxins in serum, urine and liver samples, respectively. The proposed method was further applied to the determination of the amanita toxins in suspected samples and showed great potential in the diagnosis of mushroom poisoning.

Floating molecularly imprinted polymers based on liquid crystalline and polyhedral oligomeric silsesquioxanes for capecitabine sustained release

Molecularly imprinted polymers (MIPs) have drawn extensive attention as carriers on drug delivery. However, most of MIPs suffer from insufficient drug loading capacity, burst release of drugs and/or low bioavailability. To solve the issues, this study designed an imprinted material with superior floating nature for oral drug delivery system of capecitabine (CAP) rationally. The MIPs was synthesized in the presence of 4-methylphenyl dicyclohexyl ethylene (liquid crystalline, LC) and polyhedral oligomeric silsesquioxanes (POSS) via polymerization reaction. The LC-POSS MIPs had extended release of the template molecules over 13.4 h with entrapment efficiency of 20.53%, diffusion coefficient of 2.83 × 10^-11 cm² s^-1, and diffusion exponent of 0.84. Pharmacokinetic studies further revealed the prolong release and high relative bioavailability of CAP in vivo of rats, showing the effective floating effect of the LC-POSS MIPs. The in vivo images revealed visually that the gastroretentive time of the LC-POSS MIPs was longer than non-LC-POSS imprinted polymers. The physical characteristics of the polymers were also characterized by nitrogen adsorption experiment, scanning electron microscopy, thermogravimetric analysis and differential scanning calorimetry analysis. As a conclusion, the LC-POSS MIPs can be used as an eligible CAP carrier and might hold great potential in clinical applications for sustained release drug.

Receptor-ligand interactions: Advanced biomedical applications

Receptor-ligand interactions (RLIs) are at the base of all biological events occurring in living cells. The understanding of interactions between complementary macromolecules in biological systems represents a high-priority research area in bionanotechnology to design the artificial systems mimicking natural processes. This review summarizes and analyzes RLIs in some cutting-edge biomedical fields, in particular, for the preparation of novel stationary phases to separate complex biological mixtures in medical diagnostics, for the design of ultrasensitive biosensors for identification of biomarkers of various diseases at early stages, as well as in the development of innovative biomaterials and approaches for regenerative medicine. All these biotechnological fields are closely related, because their success depends on a proper choice, combination and spatial disposition of the single components of ligand-receptor pairs on the surface of appropriately designed support.